Article Menu
- Academic Editor
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Wu, Y. Linda
- Fulgenzi, C. Angela Maria
- D’Alessio, A.
- Cheon, J.
- Nishida, N.
- Saeed, A.
- Wietharn, B.
- Cammarota, A.
- Pressiani, T.
- Personeni, N.
- Pinter, M.
- Scheiner, B.
- Balcar, L.
- Huang, Y.
- Phen, S.
- Naqash, A. Rafeh
- Vivaldi, C.
- Salani, F.
- Masi, G.
- Bettinger, D.
- Vogel, A.
- Schönlein, M.
- von Felden, J.
- Schulze, K.
- Wege, H.
- Galle, P. R.
- Kudo, M.
- Rimassa, L.
- Singal, A. G.
- Sharma, R.
- Cortellini, A.
- Gaillard, V. E.
- Chon, H. Jae
- Pinato, D. J.
- Ang, C.
- on Google Scholar
- Wu, Y. Linda
- Fulgenzi, C. Angela Maria
- D’Alessio, A.
- Cheon, J.
- Nishida, N.
- Saeed, A.
- Wietharn, B.
- Cammarota, A.
- Pressiani, T.
- Personeni, N.
- Pinter, M.
- Scheiner, B.
- Balcar, L.
- Huang, Y.
- Phen, S.
- Naqash, A. Rafeh
- Vivaldi, C.
- Salani, F.
- Masi, G.
- Bettinger, D.
- Vogel, A.
- Schönlein, M.
- von Felden, J.
- Schulze, K.
- Wege, H.
- Galle, P. R.
- Kudo, M.
- Rimassa, L.
- Singal, A. G.
- Sharma, R.
- Cortellini, A.
- Gaillard, V. E.
- Chon, H. Jae
- Pinato, D. J.
- Ang, C.
- on PubMed
- Wu, Y. Linda
- Fulgenzi, C. Angela Maria
- D’Alessio, A.
- Cheon, J.
- Nishida, N.
- Saeed, A.
- Wietharn, B.
- Cammarota, A.
- Pressiani, T.
- Personeni, N.
- Pinter, M.
- Scheiner, B.
- Balcar, L.
- Huang, Y.
- Phen, S.
- Naqash, A. Rafeh
- Vivaldi, C.
- Salani, F.
- Masi, G.
- Bettinger, D.
- Vogel, A.
- Schönlein, M.
- von Felden, J.
- Schulze, K.
- Wege, H.
- Galle, P. R.
- Kudo, M.
- Rimassa, L.
- Singal, A. G.
- Sharma, R.
- Cortellini, A.
- Gaillard, V. E.
- Chon, H. Jae
- Pinato, D. J.
- Ang, C.
Need Help?
Order Article Reprints
Journal: Cancers, 2022
Volume: 14
Number: 5834
5834
Article:
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
Authors:
by
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Rohini Sharma, Alessio Cortellini, Vincent E. Gaillard, Hong Jae Chon, David J. Pinato and Celina Angadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/14/23/5834
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Wu, Y.L.; Fulgenzi, C.A.M.; D’Alessio, A.; Cheon, J.; Nishida, N.; Saeed, A.; Wietharn, B.; Cammarota, A.; Pressiani, T.; Personeni, N.; et al. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 2022, 14, 5834. https://doi.org/10.3390/cancers14235834
Wu YL, Fulgenzi CAM, D’Alessio A, Cheon J, Nishida N, Saeed A, Wietharn B, Cammarota A, Pressiani T, Personeni N, et al. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers. 2022; 14(23):5834. https://doi.org/10.3390/cancers14235834
Chicago/Turabian StyleWu, Yue Linda, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, and et al. 2022. "Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab" Cancers 14, no. 23: 5834. https://doi.org/10.3390/cancers14235834
APA StyleWu, Y. L., Fulgenzi, C. A. M., D’Alessio, A., Cheon, J., Nishida, N., Saeed, A., Wietharn, B., Cammarota, A., Pressiani, T., Personeni, N., Pinter, M., Scheiner, B., Balcar, L., Huang, Y.-H., Phen, S., Naqash, A. R., Vivaldi, C., Salani, F., Masi, G., ... Ang, C. (2022). Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers, 14(23), 5834. https://doi.org/10.3390/cancers14235834
